S&P 500 index data: S&P 500 Copyright ©
All data supplied by Morningstar Real-Time Data. U.S. intraday real-time exchange quotes are sourced from BATS when available. End-of-day quotes for Nasdaq, NYSE, and Amex securities will appear 15 minutes after close. Graph times are Eastern Standard. © Copyright Morningstar, Inc .
|Start Premium Trial||Register For Free|
|P||F||Fund Financial Data (13,000+ funds)|
|P||F||Stock Financial Data (7,000+ stocks)|
|P||F||Stock and Fund Screeners (basic)|
|P||F||Investing Articles and Market Commentary|
|P||F||Articles Archive (>30 days)|
|P||F||Discuss (dozens of stock, fund, bond, and general bulletin boards)|
|P||F||Portfolio Manager (basic)|
|P||F||Morningstar Investment Classroom|
|P||F||Access Your Portfolio Anytime, Anywhere via Your Mobile Device|
|P||Morningstar Fund Analyst Reports (full research on 1,700 funds, ETFs, and CEFs)|
|P||Morningstar Stock Analyst Reports (full research on more than 1,100 stocks)|
|P||Portfolio Manager (advanced with 10 X-Ray analyses, including recommendations)|
|P||Portfolio Monitor (monthly and on-demand personalized portfolio statements)|
|P||Morningstar 5-Star Stock and Fund Favorites & Red Flags eNewsletters|
|P||Discounts on Morningstar newsletters, books, seminars, and more|
Join Morningstar today. It's Free.
Start your free 14-day trial today online
Your subscription may be tax deductible. Please contact your tax advisor.
|Cancer Research Technology and Teva Pharmaceuticals Form R&D Alliance for Cancer DNA Damage Response Drugs (2013/9/16)|
|Teva Provides 2014 Financial Outlook (2013/12/10)|
|Teva Pharmaceuticals and Perrigo Company Announce the U.S. Launch of Generic Temozolomide (2013/8/12)|
|Teva Reports Top-Line Results from Final Phase III Study of Armodafinil (NUVIGIL®) in Patients with Major Depression Associated with Bipolar I Disorder ()|
|Teva Announces Departure of President and CEO (2013/10/30)|
|Teva In-Focus: A Webinar Series for the Investment Community Focusing on Teva’s R&D Activities (2013/12/4)|
|Teva Announces Updates to Oncology Biologic Portfolio (2013/11/18)|
|Teva CEO Levin Steps Down ()|
|TEVA SHAREHOLDER ALERT: The Law Firm of Wohl & Fruchter LLP is Investigating Teva Pharmaceutical Industries Limited (2013/11/1)|
|Teva Pharmaceuticals And Perrigo Company Announce The U.S. Launch Of Generic Temozolomide (2013/8/12)|
Click above to view more mutual fund data and stats for teva - Teva Pharmaceutical Industries Ltd ADR.